Cognitive Behavioral Therapy + Psilocybin for major depressive disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 1 trial. Early trial in people, checking safety. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 7 Feb 2022: Trial registered, NCT05227612
  2. 27 Jun 2023: Trial started, NCT05227612

The trials

NCT05227612: Psilocybin-assisted CBT for Depression

State
Completed
Phase
Phase 1
People
16 taking part
Started
27 Jun 2023
Primary completion
12 Sep 2025
Arms
Psilocybin + CBT
Results
Posted on the registry
  1. 7 Feb 2022: Trial registered
  2. 27 Jun 2023: Trial started
  3. 12 Sep 2025: Trial completed
  4. 19 May 2026: Trial results posted

How the status changed

  1. 19 Nov 2026: First set: Phase 1 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.